Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of TG Therapeutics Inc (NASDAQ: TGTX) closed at $24.36 in the last session, down -9.44% from day before closing price of $26.90. In other words, the price has decreased by -$9.44 from its previous closing price. On the day, 9.59 million shares were traded. TGTX stock price reached its highest trading level at $25.0499 during the session, while it also had its lowest trading level at $22.92.
Ratios:
We take a closer look at TGTX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.69. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 3.58. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 20 ’24 when Lonial Sagar sold 16,348 shares for $16.87 per share. The transaction valued at 275,791 led to the insider holds 105,195 shares of the business.
Lonial Sagar sold 9,585 shares of TGTX for $157,098 on Jun 17 ’24. The Director now owns 99,293 shares after completing the transaction at $16.39 per share. On Mar 13 ’24, another insider, Lonial Sagar, who serves as the Director of the company, sold 5,000 shares for $15.94 each. As a result, the insider received 79,675 and left with 108,878 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 4149409280 and an Enterprise Value of 3754484224. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.29 while its Price-to-Book (P/B) ratio in mrq is 21.24. Its current Enterprise Value per Revenue stands at 10.828 whereas that against EBITDA is 36.808.
Stock Price History:
Over the past 52 weeks, TGTX has reached a high of $26.99, while it has fallen to a 52-week low of $9.81. The 50-Day Moving Average of the stock is 3.56%, while the 200-Day Moving Average is calculated to be 30.37%.
Shares Statistics:
According to the various share statistics, TGTX traded on average about 3.61M shares per day over the past 3-months and 2767050 shares per day over the past 10 days. A total of 151.42M shares are outstanding, with a floating share count of 137.98M. Insiders hold about 10.88% of the company’s shares, while institutions hold 59.93% stake in the company. Shares short for TGTX as of 1728950400 were 32482915 with a Short Ratio of 9.01, compared to 1726185600 on 29835522. Therefore, it implies a Short% of Shares Outstanding of 32482915 and a Short% of Float of 23.189999999999998.
